A Fully Synthetic Vaccine Consisting of a Tumor‐Associated Glycopeptide Antigen and a T‐Cell Epitope for the Induction of a Highly Specific Humoral Immune Response
- 21 November 2005
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition in English
- Vol. 44 (46) , 7630-7635
- https://doi.org/10.1002/anie.200501594
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Synthetische Vakzine aus tumorassoziierten MUC1-Glycopeptid-Antigenen und RinderserumalbuminAngewandte Chemie, 2005
- Synthetic Vaccines Consisting of Tumor‐Associated MUC1 Glycopeptide Antigens and Bovine Serum AlbuminAngewandte Chemie International Edition in English, 2005
- Cancer Immunotherapy: A Treatment for the MassesScience, 2004
- Synthetic Glycopeptides for the Development of Antitumour VaccinesAustralian Journal of Chemistry, 2003
- Cancer vaccines: progress reveals new complexitiesJournal of Clinical Investigation, 2002
- Cancer vaccinesVaccine, 2001
- Zur Entwicklung von Antitumor-Impfstoffen: ein synthetisches Konjugat aus tumorassoziiertem MUC1-Glycopeptidantigen und dem Tetanustoxin-EpitopAngewandte Chemie, 2001
- Vom Labor zur Klinik: vollsynthetische Antitumor-Impfstoffe auf KohlenhydratbasisAngewandte Chemie, 2000
- From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer VaccinesAngewandte Chemie International Edition in English, 2000
- Glycopeptide-and carbohydratebased synthetic vaccines for the immunotherapy of cancerDrug Discovery Today, 1996